Inhibitory effects of Kratom constituents, mitragynine and 7-hydroxymitragynine,...

연구 요약

Inhibitory effects of Kratom constituents, mitragynine and 7-hydroxymitragynine, on 4-methylumbelliferone glucuronidation by human UDP-glucuronosyltransferases.

Toxicology reports 학술지에 발표된 이 연구는 Uchaipichat V 외 연구팀이 수행하였습니다.

이 연구는 'Inhibitory effects of Kratom constituents, mitragynine and 7-hydroxymitragynine, on 4-methylumbelliferone glucuronidation by human UDP-glucuronosyltransferases.'에 대한 과학적 분석을 제공합니다.

핵심 내용

As Kratom use increases, concerns about potential herb-drug interactions with liver enzymes, particularly UDP-glucuronosyltransferases (UGTs), have emerged. This study investigated the inhibitory effects of Kratom leaf constituents, mitragynine and 7-hydroxymitragynine, on 4-methylumbelliferone (4MU) glucuronidation by a panel of recombinant human UGT enzymes, including UGT1A1, UGT1A3, UGT1A6, UGT1A9, UGT2B7, and UGT2B15. The degree of inhibition exhibited by mitragynine and 7-hydroxymitragynine on UGTs varied. Mitragynine exhibited the highest inhibitory potency on UGT1A3 with an IC50 value of 72 µM. Moderate inhibition potency of mitragynine were observed for UGT1A6, UGT1A9 and UGT2B15, with IC50 value of 121, 131, and 152 µM, respectively, whereas the inhibition on UGT1A1 and UGT2B7 was low (IC50 > 200 µM). 7-Hydroxymitragynine exhibited the highest inhibitory potency on UGT1A9, with IC50 value of 51 µM, while moderate potency was observed for UGT1A1 and UGT1A3, with IC50 value of 196 and 141 µM, respectively. The inhibitory potency of 7-hydroxymitragynine on UGT2B15 was low (IC50 > 200 µM), while negligible effects were observed for UGT1A6 and UGT2B7. Kinetic inhibition study revealed that mitragynine noncompetitively inhibited UGT1A3 (Ki = 45 µM) and competitively inhibited UGT1A9 (Ki = 114 µM), while 7-hydroxymitragynine competitively inhibited UGT1A3 (Ki = 33 µM) and noncompetitively inhibited UGT1A9 (Ki = 29 µM). The experimental Ki values found here are relatively high compared to the maximum plasma concentrations of mitragynine and 7-hydroxymitragynine reported in humans, suggesting an unlikely potential for herb-drug interactions via UGT inhibition.

일반인을 위한 해석

구체적인 실천 사항은 담당 의사 또는 약사와 상담하시기 바랍니다.

실천 사항

• 현재 복용 중인 약물이나 영양제에 대해 궁금한 점이 있다면 담당 의사 또는 약사와 상담하시기 바랍니다
• 약물이나 영양제의 용법·용량을 임의로 변경하지 마세요
• 이상 반응이 나타나면 즉시 전문가에게 문의하세요

의사/약사의 전문적 판단을 대체하지 않습니다 (PMID: 40026476)

📄 [전문 보기 (Markdown)](fulltext/40026476-inhibitory-effects-of-kratom-constituents-mitragynine-and-7-.md)